Skip to content

Camphor

CARDIOVASCULAR SYSTEM

Also known as: 2-Bornanone, 2-Camphanone, alphanon, borneo camphor, camphor (natural), camphor (synthetic), camphor, (+/-)-, camphor, (synthetic), camphora, DL-Camphor, root bark oil

FDA approvedATC C01EB02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Camphor is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including ache and Trpa1. Recorded indications include Arthritic Pain, Backache and Sprains and Strains.

  • Molecular targets: ache and Trpa1 (2 listed in DrugCentral).
  • Indications: Arthritic Pain, Backache and Sprains and Strains.
  • ATC code: C01EB02 (Other cardiac preparations).
  • Molecular formula: C10H16O; molecular weight 152.24 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

  • Arthritic Pain
  • Backache
  • Sprains and Strains

Contraindications (30)

  • Anemia
  • Anemia due to enzyme deficiency
  • Blister
  • Blood coagulation disorder
  • Body fluid retention
  • Breastfeeding (mother)
  • Cardiovascular event risk
  • Condyloma acuminatum
  • Denuded skin
  • Diabetes mellitus
  • Disease of liver
  • Disorder of cardiovascular system
  • Disorder of skin
  • Factor II deficiency
  • Gastritis
  • Gastroesophageal reflux disease
  • Gastrointestinal hemorrhage
  • Gastrointestinal ulcer
  • Hemophilia
  • Hepatic failure
  • Infection of skin AND/OR subcutaneous tissue
  • Inflammatory dermatosis
  • Kidney disease
  • Nasal polyp
  • Peripheral vascular disease
  • Pregnancy, function
  • Skin irritation
  • Thrombotic thrombocytopenic purpura
  • Thyrotoxicosis
  • Vitamin K deficiency

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
AcetylcholinesteraseacheunknownKi 4.30
Transient receptor potential cation channel subfamily A member 1Trpa1otherIC50 4.20

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

ATC classification

ATC codeTherapeutic hierarchy
C01EB02CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › OTHER CARDIAC PREPARATIONS › Other cardiac preparations

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Methaemoglobinaemia352.3
Joint dislocation219.8
Seronegative arthritis161.1
Joint stiffness160.3
Prescribed underdose152.3
Lupus vulgaris118.5
Hypercholesterolaemia118.4
Wound infection111.2
Walking aid user110.7
Retinitis110.4
Laryngitis110.0
Type 2 diabetes mellitus105.8

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Camphor is on its molecule page.

Molecular formulaC10H16O
Molecular weight152.24 g/mol
CAS number76-22-2
InChIKeyDSSYKIVIOFKYAU-UHFFFAOYSA-N
PubChem CID2537
CC1(C)C2CCC1(C)C(=O)C2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Camphor used for?

DrugCentral lists the following indications for Camphor: Arthritic Pain, Backache and Sprains and Strains.

How does Camphor work?

Its molecular targets in DrugCentral include ache and Trpa1.

What is the chemical formula of Camphor?

Camphor has the molecular formula C10H16O and a molecular weight of 152.24 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyFDA
Targets2
Indications3
FormulaC10H16O
DrugCentral ID470
Interactive profile